Signs and Symptoms, Digestive clinical trials
The registry lists 29 studies for Signs and Symptoms, Digestive across more than 10 countries. 1 are recruiting or about to start. 11 of them are mainly about Signs and Symptoms, Digestive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 26 narrower conditions too, such as Constipation: 5,761 studies, 926 open.
Get an email when these change. Save the Signs and Symptoms, Digestive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Furiex Pharmaceuticals, Inc (2) · Shire (2) · Société des Produits Nestlé (SPN) (2) · AstraZeneca (2) · Cargill (2) · Henan Cancer Hospital (1) · Nutrition 21, Inc. (1) · University of California, Los Angeles (1)
What is being tested here
Drugs under test in Signs and Symptoms, Digestive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Fosaprepitant | 1 | 0 | 1 |
| Probiotic | 0 | 0 | 2 |
| Eluxadoline | 0 | 1 | 2 |
| Esomeprazole | 0 | 2 | 2 |
| Butyric Acid | 0 | 0 | 1 |
| Prucalopride | 0 | 0 | 1 |
| Mycophenolic Acid | 0 | 0 | 1 |
| Z 338 | 0 | 1 | 1 |
| Gabapentin | 0 | 0 | 1 |
| Ramosetron | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Nov 2026Butyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal Disorders · Istituto Superiore di Sanità
- Sep 2027Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide · Montefiore Medical Center
Who these studies take
No Signs and Symptoms, Digestive study is recruiting now.
Across all 29 studies, recruiting or not: 72% stop at 75 or younger and 55% at 65; 28% take children; 7% are for women only and 0% for men only; 34% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 29 of 29. search them.
- Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and MetoclopramideNot yet recruitingNCT06740812Phase 41 country
- Butyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal DisordersActive, not recruitingNCT06514573Not applicable1 country
- Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal PainCompletedNCT06653647Not applicable1 country
- Anti-emetic Prophylaxis With or Without DexamethasoneCompletedNCT05242874Phase 31 country
- Efficacy And Safety Of Probiatop In The Treatment Of Digestive SymptomsCompletedNCT05603403Phase 41 country
- Evaluation of the Composition of Human Milk and Health Outcomes in ChildrenCompletedNCT01431482
- Tolerability and Functional Assessment of a Novel Children's SynbioticCompletedNCT04534036Not applicable1 country
- Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic LymphomaTerminatedNCT029285101 country
- Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 YearsCompletedNCT01424228Phase 49 countries
- Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile InfectionCompletedNCT01259726Phase 26 countries
- Effects of Probiotics and Nutritional Status on Exercise-Induced Symptoms, and Endurance Performance in Ultra-Endurance AthletesCompletedNCT04779281Not applicable1 country
- Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With DiarrheaCompletedNCT01130272Phase 21 country
- Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired ChildrenTerminatedNCT01675960Phase 21 country
- Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553747Phase 34 countries
- Effect of Ramosetron on Bowel Motility After Gynecological SurgeryStatus unknownNCT02849483Phase 41 country
- Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal FunctionStatus unknownNCT02928484Phase 1/21 country
- Fiber Tolerability in Children Aged 3-7 YearCompletedNCT02677090Not applicable1 country
- Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®CompletedNCT00652834Phase 41 country
- Fiber Tolerability in ChildrenCompletedNCT02519374Not applicable2 countries
- Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary FiberCompletedNCT02532985Not applicable
- Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary FiberCompletedNCT02530762Not applicable
- A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional DyspepsiaCompletedNCT00764374Phase 31 country
- The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress.CompletedNCT02253628Not applicable
- Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDSCompletedNCT02180035Not applicable1 country
- Clinical Trial Evaluating the Viability of L. Casei + Fish Oil CapsulesStatus unknownNCT01464814Not applicable1 country
- Nexium Dyspepsia/ASTCompletedNCT00251914Phase 317 countries
- Nexium Dyspepsia/ASTCompletedNCT00251992Phase 313 countries
- Fermented Milk Drink on Human Intestinal MicrofloraCompletedNCT00822328Phase 21 country
- Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With AutismStatus unknownNCT00110708Phase 21 country